Roche Holding AG share price down, suffers disappointment from failure of cancer drug trial
December 21, 2014 8:50 am
Roche Holding AG shares fell by the most in over five years as the Swiss company reported discouraging results from a study of two of its newer breast cancer drugs, dubbed Marianne, curbing hopes for stronger sales in one of its major markets. According to the companys statement, the breast cancer drug Kadcyla did not […] Read more